-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J4QqDgXJAJjdMeKvApHtLsy4/mNTuTJM4YCLq2ALaepftEm9B2BeNU5yy1EIdvCZ hrlN1nKuozWa9yqy9JFP8A== 0000929638-10-000547.txt : 20100816 0000929638-10-000547.hdr.sgml : 20100816 20100816151538 ACCESSION NUMBER: 0000929638-10-000547 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100630 FILED AS OF DATE: 20100816 DATE AS OF CHANGE: 20100816 EFFECTIVENESS DATE: 20100816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Camber Capital Management LLC CENTRAL INDEX KEY: 0001444043 IRS NUMBER: 421693587 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-13745 FILM NUMBER: 101019243 BUSINESS ADDRESS: STREET 1: 575 BOYLSTON STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-733-1877 MAIL ADDRESS: STREET 1: 575 BOYLSTON STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 camber13f6302010.txt 13F REPORT FOR PERIOD ENDING 6-30-2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2010 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Camber Capital Management LLC Address: 101 Huntington Avenue 25th Floor Boston, MA 02199 Form 13F File Number: 028-13745 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Stephen DuBois Title: Managing Member Phone: 617-717-6601 Signature, Place, and Date of Signing: /s/ Stephen DuBois Boston, MA August 16, 2010 [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report). [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: None Form 13F Information Table Entry Total: 34 Form 13F Information Table Value Total: 426,764 (x$1000) List of Other Included Managers: None Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. None FORM 13F INFORMATION TABLE NAME OF REPORTING MANAGER: CAMBER CAPITAL MANAGEMENT LLC As of 6/30/10
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8 Shares or Name of Title of CUSIP Value Principal SH/ PUT/ Investment Other Voting Issuer Class Number (x$1000) Amount PRN CALL Discretion Managers Authority Sole Shared None ABRAXIS BIOSCIENCE INC NEW COM 00383Y102 25,970 350,000 SH Sole n/a 350,000 AETNA INC NEW COM 00817Y108 13,190 500,000 SH Sole n/a 500,000 AMGEN INC COM 031162100 31,560 600,000 SH Sole n/a 600,000 AMGEN INC COM 031162100 10,520 200,000 CALL Sole n/a 200,000 ANADYS PHARMACEUTICALS, INC. COM 03252Q408 893 465,120 SH Sole n/a 465,120 AUXILIUM PHARMACEUTICALS. INC. COM 05334D107 17,731 754,500 SH Sole n/a 754,500 BECKMAN COULTER, INC. COM 075811109 13,565 225,000 SH Sole n/a 225,000 BOSTON SCIENTIFIC CORP COM 101137107 20,300 3,500,000 SH Sole n/a 3,500,000 BRISTOL-MYERS SQUIBB COMPANY COM 110122108 24,940 1,000,000 SH Sole n/a 1,000,000 CAREFUSION CORP COM 14170T101 20,225 892,300 SH Sole n/a 892,300 CONCEPTUS INC COM 206016107 16,582 1,064,311 SH Sole n/a 1,064,311 CRUCELL N.V. ADR 228769105 4,928 269,000 SH Sole n/a 269,000 CYPRESS BIOSCIENCES INC COM 232674507 1,150 500,000 SH Sole n/a 500,000 DYNAVAX TECHNOLOGIES CORP COM 268158102 4,272 2,296,800 SH Sole n/a 2,296,800 DYNAVAX TECHNOLOGIES CORP WARRANT 268994167 1,305 1,735,500 CALL Sole n/a 1,735,500 ELAN PLC ADR 284131208 9,000 2,000,000 SH Sole n/a 2,000,000 GILEAD SCIENCES INC COM 375558103 31,195 910,000 SH Sole n/a 910,000 GILEAD SCIENCES INC COM 375558103 8,570 250,000 CALL Sole n/a 250,000 GILEAD SCIENCES INC COM 375558103 8,570 250,000 CALL Sole n/a 250,000 HUMANA INC COM 444859102 22,835 500,000 SH Sole n/a 500,000 HUMAN GENOME SCIENCES INC COM 444903108 7,147 315,400 SH Sole n/a 315,400 MYRIAD GENETICS INC COM 62855J104 4,168 278,800 SH Sole n/a 278,800 PFIZER INC COM 717081103 24,955 1,750,000 SH Sole n/a 1,750,000 REGENERON PHARMACEUTICAL COM 75886F107 7,377 330,500 SH Sole n/a 330,500 SAVIENT PHARMACEUTICALS INC WARRANT 80517Q100 376 81,261 CALL Sole n/a 81,261 TARGACEPT, INC. COM 87611R306 4,506 233,084 SH Sole n/a 233,084 UNITEDHEALTH GROUP INC COM 91324P102 31,240 1,100,000 SH Sole n/a 1,100,000 UNIVERSAL AMERICAN CORP COM 913377107 4,727 328,241 SH Sole n/a 328,241 VIROPHARMA INC RIGHTS 928241108 0 968,341 CALL Sole n/a 968,341 VIROPHARMA INC RIGHTS 928241108 141 968,341 CALL Sole n/a 968,341 WALGREEN CO COM 931422109 12,282 460,000 SH Sole n/a 460,000 WELLCARE HEALTH PLANS INC COM 94946T106 14,600 615,000 SH Sole n/a 615,000 WELLPOINT, INC. COM 94973V107 20,795 425,000 SH Sole n/a 425,000 WRIGHT MED GROUP INC COM 98235T107 7,149 430,400 SH Sole n/a 430,400
-----END PRIVACY-ENHANCED MESSAGE-----